Lonardo A; Nascimbeni F; Ballestri S; Mascia MT; Iori R; Loria P. ( 2012 ) - Hepatocellular carcinoma in a patient treated with efalizumab for psoriasis.
- HEPATOLOGY RESEARCH
- n. volume 42
[Articolo in rivista (262) - Articolo su rivista]
Report of HCC developing in a patients receiving biologic therapies. Immunomodulation obtained through biologic agents (not only anti-TNF) recapitulates an accelerated version of the natural history of HBV infection including the development/progression of HCC. All patients undergoing to immunosuppression should be carfefkully checked and treated for hepatatis B.